共 50 条
RNA vaccines: The dawn of a new age for tuberculosis?
被引:0
|作者:
Li, Junli
[1
,2
,3
,4
]
Liu, Dong
[5
,6
]
Li, Xiaochi
[1
,2
,3
,4
]
Wei, Jiazheng
[7
]
Du, Weixin
[1
,2
,3
,4
]
Zhao, Aihua
[1
,2
,3
,4
]
Xu, Miao
[1
,2
,3
,4
]
机构:
[1] Natl Inst Food & Drug Control, Inst Biol Prod Control, Div TB Vaccine & Allergen, 31 Huatuo Rd,China Biomed Pk CBP, Beijing 102269, Peoples R China
[2] Natl Inst Food & Drug Control, State Key Lab Drug Regulatory Sci, Beijing, Peoples R China
[3] Natl Med Prod Adm NMPA, Key Lab Qual Res & Evaluat Biol Prod, Beijing, Peoples R China
[4] Natl Hlth Commiss NHC, Key Lab Res Qual & Standardizat Biotech Prod, Beijing, Peoples R China
[5] Guangzhou Med Univ, Grad Sch, Guangzhou, Peoples R China
[6] Guangzhou Lab, Guangzhou, Peoples R China
[7] Shenyang Pharmaceut Univ, Coll Life Sci & Biopharmaceut, Shenyang, Peoples R China
基金:
北京市自然科学基金;
关键词:
Tuberculosis;
mRNA vaccines;
Mycobacterium tuberculosis;
immunological mechanisms;
manufacture and quality control;
MYCOBACTERIUM-TUBERCULOSIS;
IN-VIVO;
SOUTH-AFRICA;
PURIFICATION;
TRANSLATION;
GENE;
IMMUNOGENICITY;
INITIATION;
INDUCTION;
STABILITY;
D O I:
10.1080/21645515.2025.2469333
中图分类号:
Q81 [生物工程学(生物技术)];
Q93 [微生物学];
学科分类号:
071005 ;
0836 ;
090102 ;
100705 ;
摘要:
Since 2019, there has been a growing focus on mRNA vaccines for infectious disease prevention, particularly following the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). mRNA vaccines offer advantages such as rapid production and the ability to induce robust cellular and antibody responses, which are essential for combating infections that require cell-mediated immunity, including Tuberculosis (TB). This review explores recent progress in TB mRNA vaccines and addresses several key areas: (1) the urgent need for new TB vaccines; (2) current advancements in TB vaccine development, and the advantages and challenges of mRNA technology; (3) the design and characteristics of TB mRNA vaccines; (4) the immunological mechanisms of TB mRNA vaccines; (5) manufacturing processes for TB mRNA vaccines; and (6) safety and regulatory considerations. This interdisciplinary review aims to provide insights for researchers working to address critical questions in TB mRNA vaccine development.
引用
收藏
页数:17
相关论文